Detalles de la búsqueda
1.
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).
Ann Oncol
; 23(3): 805-807, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22287683
2.
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma.
Leuk Lymphoma
; 47(10): 2174-80, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17071492
3.
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results.
Blood Cancer J
; 6: e425, 2016 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27176801
4.
PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
Thromb Res
; 140 Suppl 1: S177, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27161692
5.
Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.
Haematologica
; 93(11): e66, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18978292
6.
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Br J Cancer
; 90(2): 372-6, 2004 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-14735179
Resultados
1 -
6
de 6
1
Próxima >
>>